AiTmedservices

16/03/2021

ProFound AI Version 3.0 for Digital Breast Tomosynthesis has received FDA clearance. The third generation ProFound AI algorithm offers up to a 10% improvement in specificity performance and offers up to 40% faster processing on the new PowerLook platform. To learn more about ProFound AI 3.0, visit https://bit.ly/2Q92UX2.

22/01/2021

18/12/2020

More than one-third of people living in the U.S. have missed routine cancer screenings due to COVID-19. According to the American Cancer Society, regular screening can help find certain cancers early, when they are most likely to be treated successfully. Learn more about the role of artificial intelligence in breast cancer screening and how it can improve detection from Dr. Axel Gräwingholt at https://bit.ly/37OQpVS.

24/11/2020

ProFound AI sales has exceed 1,000 installs since the products were launched, signaling the rapid and wide-spread adoption of the pioneering cancer detection software solution built on artificial intelligence. To learn more about the products and our recently expanded suite of breast health solutions, visit https://bit.ly/3nShE8m.

19/11/2020

Our expanded suite of breast care solutions includes the latest generation of ProFound AI for digital breast tomosynthesis ( ), ProFound AI for 2D mammography*, and ProFound AI Risk, now available in the US and EU. Pre-book a virtual meeting at at https://bit.ly/3kCLJH3 to learn more. *CE Mark countries only.

03/11/2020

New and now available in the US and EU! ProFound AI™ Risk is the first and only clinical decision support tool that provides an accurate two-year, breast cancer risk estimation that is truly personalized for each woman, based only on a screening mammogram.1
The easy-to-implement solution provides superior insights1 that empower clinicians to tailor a woman’s breast screening regimen and potentially identify cancers earlier.
ProFound AI Risk uniquely combines a range of risk factors, offering superior performance in assessing short-term risk compared to traditional breast cancer risk models.1

28/10/2020

ProFound AI assists, not replaces, the radiologist when reading
mammography cases. The high-performing cancer detection and workflow solution rapidly and accurately analyzes each image, detecting both malignant soft tissue densities and calcifications with unrivaled accuracy. Learn more at https://bit.ly/31wujVH.

More than three-quarters of women prefer a radiologist to be involved with reading their screening studies.

15/10/2020